A detailed history of Voya Investment Management LLC transactions in Argenx Se stock. As of the latest transaction made, Voya Investment Management LLC holds 9,460 shares of ARGX stock, worth $4.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,460
Previous 9,460 -0.0%
Holding current value
$4.07 Million
Previous $3.6 Million 3.5%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$369.35 - $548.43 $151,433 - $224,856
410 Added 4.53%
9,460 $4.65 Million
Q1 2023

May 15, 2023

SELL
$334.23 - $403.65 $3.65 Million - $4.4 Million
-10,910 Reduced 54.66%
9,050 $3.37 Million
Q4 2022

Feb 14, 2023

SELL
$342.17 - $402.31 $128,313 - $150,866
-375 Reduced 1.84%
19,960 $7.56 Million
Q3 2022

Mar 03, 2023

BUY
$343.2 - $395.75 $128,700 - $148,406
375 Added 1.88%
20,335 $7.18 Million
Q3 2022

Nov 14, 2022

BUY
$343.2 - $395.75 $6.98 Million - $8.05 Million
20,335 New
20,335 $7.18 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $23.8B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.